Corrigendum to "Aromatic π-stacking stabilizes an α-helical SARS-CoV-2 MPER peptide that mimics the post-fusion spike and enables potent antiviral activity" [Eur. J. Med. Chem. 317 (2026) 119122]
European journal of medicinal chemistry
Latest Research
Last updated: July 17, 2026
The COVID-19 Pandemic and Changes in Cancer Screening Disparities from 2015 to 2023: An NSHAP Survey Study
Journal of general internal medicine
Environmental prevalence of enteric viruses across the covid-19 pandemic: A three-year monitoring study
Scientific reports
The Resurgence of Respiratory Viruses After COVID-19: Molecular Insights from Pediatric SARI in Kashmir
Indian journal of medical microbiology
Nirmatrelvir for acute COVID-19 to prevent long COVID (PANORAMIC Norway): a double-blind, randomised, placebo-controlled trial
The Lancet. Infectious diseases
Foundational Virology
- Zhou P, et al. "A pneumonia outbreak associated with a new coronavirus of probable bat origin." Nature, 2020. — First characterization of SARS-CoV-2 genome and bat origin.
- Andersen KG, et al. "The proximal origin of SARS-CoV-2." Nature Medicine, 2020. — Analysis of features inconsistent with deliberate engineering.
- Walls AC, et al. "Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein." Cell, 2020. — Structural basis of ACE2 binding and vaccine design target.
Clinical Disease & Treatment
- Huang C, et al. "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China." The Lancet, 2020. — First major clinical description of COVID-19 disease.
- Beigel JH, et al. "Remdesivir for the Treatment of Covid-19." NEJM, 2020. — Pivotal ACTT-1 trial establishing remdesivir benefit in hospitalized patients.
- RECOVERY Collaborative Group. "Dexamethasone in Hospitalized Patients with Covid-19." NEJM, 2021. — Landmark finding: dexamethasone reduced 28-day mortality in patients requiring oxygen.
Vaccines
- Polack FP, et al. "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine." NEJM, 2020. — Phase 3 trial: 95% efficacy, 43,448 participants.
- Baden LR, et al. "Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine." NEJM, 2021. — Moderna Phase 3 trial: 94.1% efficacy.
Epidemiology & Public Health
- Worobey M, et al. "The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic." Science, 2022.
- Wang H, et al. "Estimating excess mortality due to the COVID-19 pandemic." The Lancet, 2022. — Excess mortality estimated at 18.2 million through December 2021.
Long COVID
- Thaweethai T, et al. "Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection." JAMA, 2023. — NIH RECOVER Initiative defining Long COVID symptom clusters.
- Lopez-Leon S, et al. "More than 50 long-term effects of COVID-19: a systematic review and meta-analysis." Scientific Reports, 2021.
Key Ongoing Data Sources
- CDC COVID-19 Data Tracker — U.S. case, hospitalization, and vaccination surveillance
- WHO COVID-19 Dashboard — Global epidemiological data
- Our World in Data: COVID-19 — Comprehensive, freely accessible global data visualizations
- NIH LitCovid — Curated literature hub for COVID-19 biomedical research
- medRxiv COVID-19 Preprints — Preprint server for health sciences
